GSK Flonase tops allergy paid search study by Kantar by Beth Snyder Bulik Friday, September 14, 2018 Flonase, Claritin and Nasacort are the most-clicked brands in search ads for allergies, according to a new Kantar Media study,
Outcome pairs with Nielsen to tally its POC audience by Beth Snyder Bulik Monday, August 13, 2018 Outcome Health, still working to polish its tarnished image, teamed up with Nielsen for the POC industry's first-ever audience measurements.
Digital pharma ad spending is growing—but slowly by Beth Snyder Bulik Monday, July 9, 2018 Pharma and healthcare digital ad spending is on the rise. But it’s a slow go.
Can Cannes push pharma advertising? by Beth Snyder Bulik Monday, June 25, 2018 Pharma advertisers scored big at Cannes Lions Health with double-digit wins and renewed momentum for next year.
Pfizer cancer campaign wows at Cannes by Beth Snyder Bulik Wednesday, June 20, 2018 Pfizer's touching documentary film about patients living with cancer won praise and finalist status at the Cannes Lions Health.
Pharma nabbed 10 Cannes Lions, but once again, no Grand Prix by Beth Snyder Bulik Tuesday, June 19, 2018 Though the top prize eluded the field, 10 pharma companies racked up gold, silver or bronze Lions for their marketing and advertising efforts.
Cannes Lions Health boosts creative opps for pharma by Beth Snyder Bulik Monday, June 18, 2018 CANNES, France—Pharma keys in on opportunities to scout talent, show creative work and win awards at 2018 Cannes Lions Health.
FDA beefs up generics-use push with radio PSAs by Beth Snyder Bulik Tuesday, June 12, 2018 The FDA campaign to promote wider use of generics got a bigger media push recently with the addition of radio.
Pharma's spending more on digital but still lags consumer ads by Beth Snyder Bulik Monday, May 14, 2018 Pharma and healthcare are loading up on digital ads. Spending on digital rose to $2.53 billion in 2017, and it's expected to break $4 billion by 2020.
One Show fetes health and pharma winners by Beth Snyder Bulik Monday, May 21, 2018 The One Show’s return to health and pharma recently resulted in a slew of creative awards, but only one of them went to an actual drugmaker.
